Shihua LinDirector, Bioassay Development Biopharmaceuticals Development, R&D at AstraZeneca
Shihua is a Director of Bioassay Development at AstraZeneca. He has over 19 years’ experience in pharmaceuticals specializing in bioassay development for therapeutic biologics (mAb, bispecific, fusion protein, oncolytic virus, vaccine). Before joining AstraZeneca, he was a scientist at Teva Pharmaceuticals responsible for potency assay development and validation. During 2002 to 2011, he was a senior manager and scientist at Otsuka America Pharmaceuticals, where he was responsible for functional gene discovery, cell therapy, and therapeutic mAb R&D. He received his PhD in Neuroscience/Cell Biology from Kyoto Institute of Technology, and postdoctoral training at Wayne State University School of Medicine.